ClinicalTrials.Veeva

Menu

Quality Control of Pancreatic Islet Intended to Islet Graft Cells Intended to Stabilot Islet Graft Protocol (ISLET CHIP)

Grenoble Alpes University Hospital Center (CHU) logo

Grenoble Alpes University Hospital Center (CHU)

Status

Unknown

Conditions

Pancreatic Islet Quality Control

Study type

Observational

Funder types

Other

Identifiers

NCT03067324
38RC14.041

Details and patient eligibility

About

Islet quality control after pancreatic islets isolation process is insufficient. The Islet Chip study proposes to develop a bio-sensor that will allow a multi-parametric analysis of islet graft based on measurement of islet membrane electric potential.

Full description

Islet quality control after pancreatic islets isolation process is insufficient. The Islet Chip study proposes to develop a bio-sensor that will allow a multi-parametric analysis of islet graft based on measurement of islet membrane electric potential.

The project aims to :

  • develop the bio-sensor necessary to measure islet membrane electric potential
  • develop interface between bio-sensor and user
  • correlate analysis data collected by bio-sensor with metabolic results of islet graft

Enrollment

40 estimated patients

Sex

All

Ages

18 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients enrolled in STABILOT Pancreatic Islet cell graft protocol and willing to participate to ISLET CHIP

Exclusion criteria

  • Patients not enrolled in STABILOT Pancreatic Islet cell graft or patients that signed the form expressing their refuse to participate to ISLET CHIP.

Trial contacts and locations

8

Loading...

Central trial contact

Sandrine LABLANCHE, MD, PhD; Myriam HADDOUCHE

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems